Le Lézard
Classified in: Health, Science and technology

Space-Made Fibers and Novel Biotech Among Research Returning to Earth After Successful Space Station Mission


SpaceX's 30th Commercial Resupply Services Mission for NASA returns to Earth after more than 35 days onboard the International Space Station

KENNEDY SPACE CENTER, Fla., April 30, 2024 /PRNewswire/ -- Research on a novel vision loss therapy and space-manufactured optical fibers were among the nearly 565 pounds of science and technology payloads sponsored by the International Space Station (ISS) National Laboratory that splashed down off the Florida coast Tuesday morning as NASA concluded SpaceX's 30th Commercial Resupply Services (CRS) mission.

The return of the SpaceX Dragon capsule brings back more than 40 ISS National Lab-sponsored investigations that aim to benefit humanity and foster commerce in low Earth orbit. Among the payloads returning to Earth for analysis are the following:

These are just a few of the investigations returning to Earth in the SpaceX Dragon capsule on this mission. To learn more about all of the ISS National Lab payloads on SpaceX CRS-30, please visit our launch page.

To download a high-resolution photo for this release, click here. 

About the International Space Station (ISS) National Laboratory:
The International Space Station (ISS) is a one-of-a-kind laboratory that enables research and technology development not possible on Earth. As a public service enterprise, the ISS National Laboratory® allows researchers to leverage this multiuser facility to improve quality of life on Earth, mature space-based business models, advance science literacy in the future workforce, and expand a sustainable and scalable market in low Earth orbit. Through this orbiting national laboratory, research resources on the ISS are available to support non-NASA science, technology, and education initiatives from U.S. government agencies, academic institutions, and the private sector. The Center for the Advancement of Science in Spacetm (CASIStm) manages the ISS National Lab, under Cooperative Agreement with NASA, facilitating access to its permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space. To learn more about the ISS National Lab, visit our website.

As a 501(c)(3) nonprofit organization, CASIS accepts corporate and individual donations to help advance science in space for the benefit of humanity. For more information, visit our donations page.

Media Contact:         

Patrick O'Neill 


904-806-0035 


[email protected]


International Space Station (ISS) National Laboratory
Managed by the Center for the Advancement of Science in Space, Inc. (CASIS)

6905 N. Wickham Rd., Suite 500, Melbourne, FL 32940 ? 321.253.5101 ? www.ISSNationalLab.org

 

SOURCE International Space Station National Lab


These press releases may also interest you

at 20:23
Fluence, a global leader in evidence-based psychedelic therapy training, has announced a partnership with Metamorph AI, a pioneering AI technology company, to develop an AI-powered tool to enhance the training of psychedelic therapists. We believe...

at 18:30
Next Gen Diagnostics (NGD) and a team at Vanderbilt University Medical Center (VUMC) today announced the results of a study reporting that comparison of the whole genome sequence (WGS) of bacterial pathogens obtained from surveillance of infants in a...

at 17:21
Community Healthcare Trust Incorporated (the "Company") today announced the release of its inaugural Corporate Sustainability Report for the year 2023. This comprehensive report highlights the Company's commitment to environmental stewardship,...

at 17:14
BJC HealthCare, one of the largest nonprofit health care organizations in the United States, and Encompass Health , the nation's largest owner and operator of inpatient rehabilitation hospitals, announce the opening of The Rehabilitation Institute of...

at 17:04
Cano Health, Inc. ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's...

at 17:00
Eupraxia Pharmaceuticals...



News published on and distributed by: